EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

INDUCTION CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIOTHERAPY VERSUS CONCURRENT CHEMORADIOTHERAPY ALONE IN LOCALLY ADVANCED NASOPHARYNGEAL CANCER

Sajib Kumar Talukdhar*, Sarwar Alam, Md. Abdul Bari, Md. Zillur Rahman Bhuiyan, Sadia Sharmin and Md. Abdullah Al Maruf

ABSTRACT

Background: Concurrent chemoradiotherapy is the standard of care for patients with locally advanced nasopharyngeal carcinoma. Addition of induction chemotherapy remains unclear. Objective: The aim of this study was to compare the treatment response and toxicity of induction chemotherapy followed by concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced nasopharyngeal cancers. Materials and Methods: This quasi-experimental study was carried out among 80 patients of locally advanced squamous cell carcinoma of nasopharynx from June, 2018 to June, 2019. Who had fulfilled the inclusion and exclusion criteria were included and equally distributed into two treatment arms. Arm A received induction chemotherapy followed by concurrent chemoradiotherapy and Arm B received concurrent chemoradiotherapy alone. Results: Final responses were evaluated 3 months after the end of treatment. In Arm A, 27 (67.5%) patients showed complete response (CR) and in Arm B, CR was observed in 15 (37.5%) patients. Partial responses (PR) were 11 (27.5%) and 21 (52.5%) in two arms respectively. There were 02 (5.0%) progressive disease (PD) in Arm A and 04 (10.0%) PD in Arm B. Treatment responses were statistically significant between two groups (p-value=0.032). Toxic effects during chemoradiotherapy were almost similar in the two arms. Conclusion: Induction chemotherapy followed by concurrent chemoradiotherapy is more effective than concurrent chemoradiotherapy alone in locally advanced squamous cell carcinoma of nasopharynx with acceptable toxicities.

Keywords: Nasopharyngeal cancer, Squamous cell carcinoma, Induction chemotherapy, Concurrent chemoradiotherapy.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2020 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2020 Issue has been successfully launched on 1 November 2020.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing